Legal Representation
Attorney
Jeffrey S. Boone
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 27, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 27, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 28, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 10, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 10, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 5, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 27, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 27, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 27, 2007 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 27, 2007 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 27, 2007 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 27, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 2, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 13, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 13, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 7, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 1, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 12, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 29, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 29, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 3, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 3, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 29, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 30, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparation for the treatment of nausea and vomiting in cancer patients
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005